Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
89,748,415
-
Total 13F shares
-
72,978,794
-
Share change
-
+1,941,256
-
Total reported value
-
$1,535,405,782
-
Put/Call ratio
-
115%
-
Price per share
-
$21.03
-
Number of holders
-
153
-
Value change
-
+$36,464,951
-
Number of buys
-
83
-
Number of sells
-
80
Institutional Holders of Travere Therapeutics, Inc. - Common Shares (TVTX) as of Q4 2022
As of 31 Dec 2022,
Travere Therapeutics, Inc. - Common Shares (TVTX) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,978,794 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Deep Track Capital, LP, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., MACQUARIE GROUP LTD, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
153
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.